HomeInsightsStock Comparison

Piramal Pharma Ltd vs Sms Pharmaceuticals Ltd Stock Comparison

Piramal Pharma Ltd vs Sms Pharmaceuticals Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Piramal Pharma Ltd is ₹ 190.6 as of 01 Aug 15:30.
  • The P/E Ratio of Piramal Pharma Ltd changed from 991.5 on March 2024 to 325.4 on March 2025 . This represents a CAGR of -42.71% over 2 yearsThe P/E Ratio of SMS Pharmaceuticals Ltd changed from 7.1 on March 2020 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The Market Cap of Piramal Pharma Ltd changed from ₹ 8165 crore on March 2023 to ₹ 29763 crore on March 2025 . This represents a CAGR of 53.90% over 3 yearsThe Market Cap of SMS Pharmaceuticals Ltd changed from ₹ 225.6 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The revenue of Piramal Pharma Ltd for the Jun '25 is ₹ 2031 crore as compare to the Mar '25 revenue of ₹ 2812 crore. This represent the decline of -27.77% The revenue of SMS Pharmaceuticals Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 249.62 crore. This represent the decline of -100%.
  • The ebitda of Piramal Pharma Ltd for the Jun '25 is ₹ 204.41 crore as compare to the Mar '25 ebitda of ₹ 619.24 crore. This represent the decline of -66.99% The ebitda of SMS Pharmaceuticals Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 42.23 crore. This represent the decline of -100%.
  • The net profit of Piramal Pharma Ltd changed from ₹ -98.58 crore to ₹ -81.7 crore over 9 quarters. This represents a CAGR of -8.01% The net profit of SMS Pharmaceuticals Ltd changed from ₹ 8.81 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Piramal Pharma Ltd changed from 18.07 % on March 2022 to 2.68 % on March 2025 . This represents a CAGR of -37.94% over 4 yearsThe Dividend Payout of SMS Pharmaceuticals Ltd changed from 6.48 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Piramal Pharma Ltd

  • Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
  • It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
  • In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. PPL is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.
  • It operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (CDMO) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (CHG) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and India consumer healthcare (ICH) business, selling well-known OTC brands.

About SMS Pharmaceuticals Ltd

  • SMS Pharmaceuticals Limited was incorporated in December, 1987.
  • The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates.
  • Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa Village in Vijayanagaram District of Andhra Pradesh. During the year 2015, the company has re-enforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities. During the year 2015, the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24. During the year 2014-15, the Company acquired 12,25,900 equity shares of Rs. 10/- each in M/s.
  • VKT Pharma Private Limited.

Piramal Pharma Ltd News Hub

News

Piramal Pharma grants 20,20,507 stock options

The Board of Piramal Pharma at its meeting held on 28 July 2025 has approved the grant of ...

Read more

29 Jul 2025 09:47

News

Piramal Pharma posts loss of Rs 82 crore in Q1; EBITDA margin declines to 9%

Revenue from operations for the period under review declined by 1% year-over-year (YoY) to...

Read more

29 Jul 2025 09:30

News

Piramal Pharma to sell its decommissioned unit in MIDC, Thane for Rs 8.50 cr

Piramal Pharma announced that the Administrative Committee of the Board, at its meeting he...

Read more

22 Jul 2025 16:23

News

Piramal Pharma receives upgrade in LT credit ratings

Piramal Pharma announced that CARE has revised the credit ratings assigned to the company ...

Read more

21 Jul 2025 13:15

News

Piramal Pharma to announce Quarterly Result

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 28 July 202...

Read more

19 Jul 2025 09:22

News

Piramal Pharma to conduct AGM

Piramal Pharma announced that the 5th Annual General Meeting(AGM) of the company will be h...

Read more

14 Jun 2025 14:54

SMS Pharmaceuticals Ltd News Hub

News

SMS Pharma's Hyderabad facility clears USFDA inspection with zero observations

The inspection was conducted from 23rd June 2025 to 25th June 2025, concluded with zero Fo...

Read more

26 Jun 2025 08:27

News

Board of SMS Pharmaceuticals recommends final dividend

SMS Pharmaceuticals announced that the Board of Directors of the Company at its meeting he...

Read more

31 May 2025 14:45

News

SMS Pharmaceuticals to announce Quarterly Result

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May...

Read more

24 May 2025 18:31

News

SMS Pharmaceuticals' Unit VII receives WHO Geneva prequalification

SMS Pharmaceuticals announced that Unit VII manufacturing facility in Visakhapatnam, Andhr...

Read more

02 May 2025 12:36

News

SMS Pharma gains after Hyderabad facility completes USFDA inspection

According to an exchange filing, the inspection was conducted from 17 March to 21 March 20...

Read more

24 Mar 2025 09:59

News

SMS Pharma's Hyderabad facility completes USFDA inspection with 1 observation

According to an exchange filing, the inspection was conducted from 17 March to 21 March 20...

Read more

22 Mar 2025 16:28

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of SMS Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

2

T

BlinkX Score for Piramal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for SMS Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Piramal Pharma Ltd and SMS Pharmaceuticals Ltd

Which company has a larger market capitalization, Piramal Pharma Ltd or SMS Pharmaceuticals Ltd?

Market cap of Piramal Pharma Ltd is 25,335 Cr while Market cap of SMS Pharmaceuticals Ltd is 2,027 Cr

What are the key factors driving the stock performance of Piramal Pharma Ltd and SMS Pharmaceuticals Ltd?

The stock performance of Piramal Pharma Ltd and SMS Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Piramal Pharma Ltd and SMS Pharmaceuticals Ltd?

As of August 2, 2025, the Piramal Pharma Ltd stock price is INR ₹190.6. On the other hand, SMS Pharmaceuticals Ltd stock price is INR ₹228.65.

How do dividend payouts of Piramal Pharma Ltd and SMS Pharmaceuticals Ltd compare?

To compare the dividend payouts of Piramal Pharma Ltd and SMS Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions